July 2005
Volume 46, Issue 7
Free
Clinical and Epidemiologic Research  |   July 2005
Overnight Thickness Variation in Diabetic Macular Edema
Author Affiliations
  • Michael Larsen
    From the Department of Ophthalmology, Herlev Hospital, University of Copenhagen, Denmark.
  • Maria Wang
    From the Department of Ophthalmology, Herlev Hospital, University of Copenhagen, Denmark.
  • Birgit Sander
    From the Department of Ophthalmology, Herlev Hospital, University of Copenhagen, Denmark.
Investigative Ophthalmology & Visual Science July 2005, Vol.46, 2313-2316. doi:https://doi.org/10.1167/iovs.04-0893
  • Views
  • PDF
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Michael Larsen, Maria Wang, Birgit Sander; Overnight Thickness Variation in Diabetic Macular Edema. Invest. Ophthalmol. Vis. Sci. 2005;46(7):2313-2316. https://doi.org/10.1167/iovs.04-0893.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

purpose. To study the evening-to-morning variation in retinal thickness in patients with fovea-involving diabetic macular edema.

methods. Twelve eyes in 12 patients aged 39 to 78 years (mean, 57) with fovea-involving diabetic macular edema and 14 eyes in 7 healthy volunteers aged 30 to 70 years (mean, 57) were examined by optical coherence tomography, in the evening and in the morning after ≥6 hours of sleep in the recumbent position in darkness followed by 0.5 hour wakefulness in the same position in room light with both eyes open.

results. In patients with diabetic macular edema, macular thickness increased overnight, from 316 ± 72 μm in the evening to 336 ± 81 μm in the morning (P = 0.003). Visual acuity decreased from a mean of 41 ETDRS letters (Early Treatment of Diabetic Retinopathy Study; range, 4–61) in the evening, to a mean of 36 letters (range, 2–60) in the morning (P = 0.03). No overall change was found in mean arterial blood pressure (MABP; P = 0.48), blood glucose (P = 0.25), or corneal thickness (P = 0.26). The overnight change in macular thickness correlated directly with the change in MABP (r = 0.65, P = 0.03) but not with baseline MABP or blood glucose. The overnight increase in retinal thickness remained significant after statistical adjustment for the effect of arterial blood pressure (P = 0.002). Healthy subjects demonstrated no significant change in any parameter.

conclusions. In fovea-involving diabetic macular edema, a reduction in visual acuity accompanies overnight retinal thickening, the magnitude being related to the nocturnal change in blood pressure. The results indicate that deficient regulation of retinal capillary filling pressure promotes edema, but the bulk of the overnight increase in macular edema is caused by other mechanisms, of which postural variation in venous blood pressure and increased retinal metabolism in the dark merit further study.

Diabetic patients with macular edema occasionally report poorer reading vision early in the morning than later in the day, 1 with reading improving spontaneously within 2 to 4 hours after rising. A variety of mechanisms may be postulated to explain this phenomenon. Our working hypothesis was that the change in visual acuity is caused by an increase in foveal edema during sleep in the recumbent position. To test the hypothesis we compared foveal thickness before and after sleep in patients with diabetic macular edema (DME) and in healthy subjects. 
Methods
The study adhered to the tenets of the Declaration of Helsinki and was approved by the medical ethics committee of Copenhagen County. Included were 14 eyes of 7 healthy volunteers (4 men, 3 women) aged 30 to 70 years (mean, 57) and 12 eyes in 12 patients aged 39 to 78 years (mean, 57; men, 3 women) with DME exceeding the ETDRS (Early Treatment Diabetic Retinopathy Study) clinically significant macular edema level and extending to within 500 μm of the center of the foveola. 2 Inclusion required independent verification of edema by biomicroscopy, intravenous fluorescein angiography (IVFA), and optical coherence tomography (OCT) and ability to fixate the OCT fixation target. None of the participants had current or previous eye disease other than diabetic retinopathy or significant systemic disease other than diabetes and systemic complications of diabetes in the patient group. No participant had refractive error exceeding ±5 spherical diopters or ±3 cylindrical diopters. Applanation tonometry at study entry was below 21 mm Hg in all eyes. We enrolled the first 12 eligible volunteers with foveal-center–involving DME, as defined by the mean +2 SD of healthy subjects, according to Wang et al. 3  
Study procedures included ETDRS refraction and determination of best-corrected visual acuity, 4 biomicroscopy with a Goldmann contact lens, fundus photography, IVFA, blood pressure manometry in the sitting position in the evening and in the recumbent position in the morning until immediately before rising to have OCT performed, and blood glucose measurement with a test strip. Retinal thickness was assessed with horizontal fovea-centered 4.52-mm wide OCT scans (OCT-1, software ver. CA A4.1, nominal axial resolution of 10 μm; Carl Zeiss Meditec, Dublin, CA). Macular thickness was defined as the mean of the entire scan, taken as seven evenly spaced positions along the scan, one in the center of the scan, presumably corresponding to the center of the foveola, and three on either side, extending to the end of the scan. Foveal thickness was defined as the value of the reading at the center of the scan. The assessment of the posterior and anterior surfaces of the neurosensory retina was guided by the automated tracing of a manufacturer-supplied tracking algorithm, which was evaluated visually, corrected as needed, and read with a ruler. All values were based on the mean of the two best-quality scans from the same session. All OCT procedures and evaluations were performed by the same observer. All patients were examined before photocoagulation treatment. 
Retinal thickness was measured in the evening between 8 and 10 PM, after the patient had been no less than 6 hours in the sitting or standing position and in the morning after the patient had been awake for 0.5 hour in normal room light while maintaining the recumbent position with both eyes opened. Visual acuity was expressed as the numbers of letters read on the ETDRS chart and/or the logMAR (logarithm of the minimum angle of resolution) value. Variations in observational parameters were analyzed by using Wilcoxon’s matched-pairs signed rank sum test and differences between groups using the Kruskal-Wallis nonparametric test. Correlations between parameters were analyzed with the Pearson test. All tests were made assuming a level of statistical significance of P < 0.05. 
Results
In healthy subjects, macular thickness over the full 4.52-mm width of the OCT scans was stable, at 239 ± 17 μm in the evening (mean ± SD) and 237 ± 15 μm in the morning (P = 0.50). Best-corrected visual acuity in the evening was 57 ± 4 letters (mean ± SD; logMAR, −0.04) and 57 ± 5 letters in the morning (logMAR −0.04; P = 0.45). Healthy subjects also demonstrated no significant overnight variation in MABP (P = 0.50), blood glucose (P = 0.20), or corneal thickness (P = 0.09). 
In patients with DME, macular thickness over the full 4.52-mm width of the OCT scan increased overnight by an average of 6.3%, from 316 ± 72 (mean ± SD) μm in the evening to 336 ± 81 μm in the morning (Figs. 1 2 ; P = 0.003; Table 1 ). The thickness of the center of the foveola increased overnight by an average of 11.9%, from 336 ± 103 μm in the evening to 376 ± 122 μm in the morning (P = 0.004). A concomitant decrease in best-corrected visual acuity was seen overnight, from 41 ± 14 letters (mean ± SD, range, 4–61) in the evening to 36 ± 11 letters in the morning (P = 0.03; Table 2 ). Of the 10 patients who experienced an increase in foveal center thickness of 5% or more relative to baseline, 7 had a decrease in acuity of five or more ETDRS letters overnight. The correlation between the changes in visual acuity and retinal thickness did not achieve statistical significance (r = 0.029; P = 0.20). 
The change in macular thickness in patients with DME correlated positively with the change in MABP (r = 0.65, P = 0.03; Fig. 3 ) but not with baseline blood pressure or blood glucose. After adjustment for the statistical effect of changes in MABP, the overnight increase in retinal thickness remained statistically significant (P = 0.002; parametric regression analysis). No overall change was found in MABP (P = 0.48), blood glucose (P = 0.25), corneal thickness (P = 0.26), or refraction (P = 0.63). 
Discussion
We have shown that the healthy retina is capable of maintaining a stable thickness from evening to morning and that in eyes with DME, it undergoes significant overnight thickening accompanied by a reduction in visual acuity. Apparently, the mechanisms that maintain the equilibrium between production and removal of extracellular fluid in the healthy retina are exhausted in DME, such that sleeping in the recumbent position induces a shift to a level of higher intraretinal fluid content. 
Our study independently confirms a previous OCT study that followed patients from 8 AM until 5 PM with a newer OCT instrument and a full macular-thickness mapping technique based on rapid sequences of radial transfoveal scans. 5 The study demonstrated that most of the overnight swelling subsides before noon. The levels of macular edema were comparable to those in the present study, in which we were able to document poorer visual acuity in the morning than in the evening. This is in agreement with the report of Sternberg et al. 1 and the sporadic complaints of patients that prompted us to conduct this study. 
We have also shown that the overnight change in retinal thickness is proportional to variations in arterial blood pressure. This is of particular relevance in diabetes, because a large proportion of patients have impaired nocturnal blood pressure regulation. 6 This observation indicates that the retinal capillary filling pressure is important in producing DME. Nevertheless, the larger part of the overnight increase in macular thickness seems to occur independent of changes in arterial blood pressure. Other mechanisms involved in the maintenance of retinal edema include the osmotic effect of extravasated plasma macromolecules; the increased permeability of the retinal vessels; and the mechanical compliance of the swollen retina and its internal hydrostatic pressure gradients, both of which are entirely unknown; and the venous pressure in the retina. The orbital venous pressure increases when changing position from standing to lying down, from nearly zero to roughly the pressure in the right atrium. Changes of this magnitude do not occur in the retina, because venous pressure is never lower than the intraocular pressure. A change toward a more reclining position induces only a small increase in intraocular pressure in healthy subjects, but a considerably larger increase can be seen in subjects with autonomic failure, which is common among people with diabetes. 7 8 Increasing intraocular pressure will decrease the transmural pressure gradient in the retinal capillaries. Hence, such postural effects on macular edema should cause a conservative bias in the results of the study. 
We were unable to demonstrate any effect of overnight fluctuations in blood glucose. Our study population was unlikely to have been exposed to nocturnal hypoglycemia, because, of the 12 patients, only 4 received insulin treatment; and, of those, only 2 had type 1 diabetes. In addition, blood glucose measurements before and after sleep revealed no evidence of hypoglycemia. 
In summary, we have confirmed that an overnight increase in DME is the rule rather than the exception when the fovea is involved, and we have shown that macular thickening often is associated with a concomitant reduction in visual acuity. Variation in arterial blood pressure was found to influence the process of edema formation, but orthostatic variation in venous blood pressure 9 and increased retinal metabolism 10 in the dark are other mechanisms that should be considered. 
 
Figure 1.
 
Difference in macular thickness between evening and morning after an overnight sleep followed by a 0.5-hour rest with open eyes in room light in the recumbent position, in 14 eyes in 7 healthy control subjects and in 12 eyes in 12 patients with DME. Healthy subjects demonstrated no systematic variation, whereas a nocturnal–recumbent increase was measured in eyes with DME, from 316 ± 72 μm (mean ± SD) to 336 ± 81 μm (+6.3%; P = 0.003). In 8 of 12 eyes with DME, the increase exceeded the mean +2 SD of the variation found in healthy subjects.
Figure 1.
 
Difference in macular thickness between evening and morning after an overnight sleep followed by a 0.5-hour rest with open eyes in room light in the recumbent position, in 14 eyes in 7 healthy control subjects and in 12 eyes in 12 patients with DME. Healthy subjects demonstrated no systematic variation, whereas a nocturnal–recumbent increase was measured in eyes with DME, from 316 ± 72 μm (mean ± SD) to 336 ± 81 μm (+6.3%; P = 0.003). In 8 of 12 eyes with DME, the increase exceeded the mean +2 SD of the variation found in healthy subjects.
Figure 2.
 
Transfoveal horizontal OCT from the right eye of a woman aged 53 years (patient 2) with DME. Two identically located scans were recorded, one in the evening (left) and one in the morning (right) after overnight sleep followed by a 0.5-hour rest with open eyes in the recumbent position. Best-corrected visual acuity was 20/32 in the evening and 20/80 in the morning. Maximum retinal thickness, which was achieved approximately 300 μm off the foveal center, was 420 μm in the evening and 496 μm in the morning, an 18% increase.
Figure 2.
 
Transfoveal horizontal OCT from the right eye of a woman aged 53 years (patient 2) with DME. Two identically located scans were recorded, one in the evening (left) and one in the morning (right) after overnight sleep followed by a 0.5-hour rest with open eyes in the recumbent position. Best-corrected visual acuity was 20/32 in the evening and 20/80 in the morning. Maximum retinal thickness, which was achieved approximately 300 μm off the foveal center, was 420 μm in the evening and 496 μm in the morning, an 18% increase.
Table 1.
 
Characteristics and Retinal Thickness of Patients with DME
Table 1.
 
Characteristics and Retinal Thickness of Patients with DME
Pt. No. Age (y) Gender Eye Diabetes Type Insulin Treatment Retinal Thickness (μm)
Macula, Evening Macula, Morning Absolute Difference Relative Difference (%) Fovea, Evening Fovea, Morning Absolute Difference Relative Difference (%)
1 53/M OD 2 N 354 383 28 8 394 444 50 13
2 53/F OD 2 N 299 346 47 16 325 434 109 34
3 55/F OS 2 N 273 277 5 2 259 251 −8 −3
4 52/M OD 2 N 321 328 7 2 367 410 43 12
5 48/M OS 1 Y 262 279 16 6 272 342 69 25
6 59/M OD 2 N 506 546 41 8 597 665 68 11
7 78/M OD 2 N 270 292 21 8 340 360 20 6
8 51/M OD 2 N 349 382 33 9 411 476 65 16
9 70/M OD 2 N 308 307 −2 −1 251 254 3 1
10 68/M OS 2 Y 353 374 21 6 332 348 16 5
11 39/F OD 1 Y 261 285 24 9 282 319 37 13
12 53/M OD 2 Y 230 236 6 3 204 214 10 5
Mean 56.6 316 336 21 6 336 376 40 11
SD 10.7 72 81 15 4 103 122 34 10
Table 2.
 
Visual Acuity, MABP, and Plasma Glucose in Patients with DME
Table 2.
 
Visual Acuity, MABP, and Plasma Glucose in Patients with DME
Pt. No. Visual Acuity (ETDRS Letters) MABP (mm Hg) Plasma Glucose (mM)
Evening Morning Absolute Difference Relative Difference (%) Evening Morning Absolute Difference Relative Difference (%) Evening Morning Absolute Difference Relative Difference (%)
1 35 35 0 0 111 130 19 17 5.1 6.3 1.2 23.5
2 43 27 −16 −37 98 101 3 3 11.0 9.3 −1.7 −15.5
3 46 44 −2 −4 108 83 −25 −23 N/A N/A 0.0
4 61 59 −2 −3 105 97 −8 −8 7.9 5.2 −2.7 −34.2
5 53 47 −6 −11 106 109 3 3 N/A N/A 0.0
6 4 19 15 375 89 105 16 18 7.1 8.1 1.0 14.1
7 35 32 −3 −9 90 100 10 11 10.4 10.6 0.2 1.9
8 35 26 −9 −26 104 125 21 21 4.7 5.1 0.4 8.5
9 43 35 −8 −19 118 123 5 4 6.7 5.4 −1.3 −19.4
10 50 45 −5 −10 108 110 2 2 N/A N/A 0.0
11 47 29 −18 −38 97 97 0 0 4.4 10.1 5.7 129.5
12 41 29 −12 −29 103 82 −21 −20 14.3 7.8 −6.5 −45.5
Mean 41 36 −6 16 103 105 2 2 8 8 0 7.0
SD 14 11 9 114 8 15 14 14 3 2 3 51.3
Figure 3.
 
Relative overnight change in macular thickness versus relative change in MABP in 12 patients with fovea-involving DME as assessed with horizontal transfoveal OCT. The overnight change in macular thickness increased in proportion to the change in MABP (r = 0.65, P = 0.03, Wilcoxon). An overnight increase was found in 11 of 12 eyes in 12 patients, and this finding was unaltered by statistical adjustment for the effect of MABP (P = 0.002; parametric regression analysis).
Figure 3.
 
Relative overnight change in macular thickness versus relative change in MABP in 12 patients with fovea-involving DME as assessed with horizontal transfoveal OCT. The overnight change in macular thickness increased in proportion to the change in MABP (r = 0.65, P = 0.03, Wilcoxon). An overnight increase was found in 11 of 12 eyes in 12 patients, and this finding was unaltered by statistical adjustment for the effect of MABP (P = 0.002; parametric regression analysis).
SternbergP, Jr, FitzkeF, FinkelsteinD. Cyclic macular edema. Am J Ophthalmol. 1982;94:664–669. [CrossRef] [PubMed]
Early Treatment Diabetic Retinopathy Study research group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study Report number 1. Arch Ophthalmol. 1985;103:1796–1806. [CrossRef] [PubMed]
WangMS, SanderB, LarsenM. Retinal atrophy in idiopathic central serous chorioretinopathy. Am J Ophthalmol. 2002;133:787–793. [CrossRef] [PubMed]
KleinR, KleinBE, MossSE, DeMetsD. Inter-observer variation in refraction and visual acuity measurement using a standardized protocol. Ophthalmology. 1983;90:1357–1359. [CrossRef] [PubMed]
FrankRN, SchulzL, AbeK, IezziR. Temporal variation in diabetic macular edema measured by optical coherence tomography. Ophthalmology. 2004;111:211–217. [CrossRef] [PubMed]
MakabeR. Orthostatic cephalic hypotension and the eye. Klin Monatsbl Augenheilkd. 1975;166:56–58. [PubMed]
NielsenFS, RossingP, BangLE, et al. On the mechanisms of blunted nocturnal decline in arterial blood pressure in NIDDM patients with diabetic nephropathy. Diabetes. 1995;44:783–789. [CrossRef] [PubMed]
DumskyjMJ, MathiasCJ, DoreCJ, Bleasdale-BarrK, KohnerEM. Postural variation in intraocular pressure in primary chronic autonomic failure. J Neurol. 2002;249:712–718. [CrossRef] [PubMed]
ChristoffersenN, LarsenM. Unilateral diabetic macular oedema secondary to central retinal vein congestion. Acta Ophthalmol Scand. 2004;82:591–595. [CrossRef] [PubMed]
LinsenmeierRA. Effects of light and darkness on oxygen distribution and consumption in the cat retina. J Gen Physiol. 1986;88:521–542. [CrossRef] [PubMed]
Figure 1.
 
Difference in macular thickness between evening and morning after an overnight sleep followed by a 0.5-hour rest with open eyes in room light in the recumbent position, in 14 eyes in 7 healthy control subjects and in 12 eyes in 12 patients with DME. Healthy subjects demonstrated no systematic variation, whereas a nocturnal–recumbent increase was measured in eyes with DME, from 316 ± 72 μm (mean ± SD) to 336 ± 81 μm (+6.3%; P = 0.003). In 8 of 12 eyes with DME, the increase exceeded the mean +2 SD of the variation found in healthy subjects.
Figure 1.
 
Difference in macular thickness between evening and morning after an overnight sleep followed by a 0.5-hour rest with open eyes in room light in the recumbent position, in 14 eyes in 7 healthy control subjects and in 12 eyes in 12 patients with DME. Healthy subjects demonstrated no systematic variation, whereas a nocturnal–recumbent increase was measured in eyes with DME, from 316 ± 72 μm (mean ± SD) to 336 ± 81 μm (+6.3%; P = 0.003). In 8 of 12 eyes with DME, the increase exceeded the mean +2 SD of the variation found in healthy subjects.
Figure 2.
 
Transfoveal horizontal OCT from the right eye of a woman aged 53 years (patient 2) with DME. Two identically located scans were recorded, one in the evening (left) and one in the morning (right) after overnight sleep followed by a 0.5-hour rest with open eyes in the recumbent position. Best-corrected visual acuity was 20/32 in the evening and 20/80 in the morning. Maximum retinal thickness, which was achieved approximately 300 μm off the foveal center, was 420 μm in the evening and 496 μm in the morning, an 18% increase.
Figure 2.
 
Transfoveal horizontal OCT from the right eye of a woman aged 53 years (patient 2) with DME. Two identically located scans were recorded, one in the evening (left) and one in the morning (right) after overnight sleep followed by a 0.5-hour rest with open eyes in the recumbent position. Best-corrected visual acuity was 20/32 in the evening and 20/80 in the morning. Maximum retinal thickness, which was achieved approximately 300 μm off the foveal center, was 420 μm in the evening and 496 μm in the morning, an 18% increase.
Figure 3.
 
Relative overnight change in macular thickness versus relative change in MABP in 12 patients with fovea-involving DME as assessed with horizontal transfoveal OCT. The overnight change in macular thickness increased in proportion to the change in MABP (r = 0.65, P = 0.03, Wilcoxon). An overnight increase was found in 11 of 12 eyes in 12 patients, and this finding was unaltered by statistical adjustment for the effect of MABP (P = 0.002; parametric regression analysis).
Figure 3.
 
Relative overnight change in macular thickness versus relative change in MABP in 12 patients with fovea-involving DME as assessed with horizontal transfoveal OCT. The overnight change in macular thickness increased in proportion to the change in MABP (r = 0.65, P = 0.03, Wilcoxon). An overnight increase was found in 11 of 12 eyes in 12 patients, and this finding was unaltered by statistical adjustment for the effect of MABP (P = 0.002; parametric regression analysis).
Table 1.
 
Characteristics and Retinal Thickness of Patients with DME
Table 1.
 
Characteristics and Retinal Thickness of Patients with DME
Pt. No. Age (y) Gender Eye Diabetes Type Insulin Treatment Retinal Thickness (μm)
Macula, Evening Macula, Morning Absolute Difference Relative Difference (%) Fovea, Evening Fovea, Morning Absolute Difference Relative Difference (%)
1 53/M OD 2 N 354 383 28 8 394 444 50 13
2 53/F OD 2 N 299 346 47 16 325 434 109 34
3 55/F OS 2 N 273 277 5 2 259 251 −8 −3
4 52/M OD 2 N 321 328 7 2 367 410 43 12
5 48/M OS 1 Y 262 279 16 6 272 342 69 25
6 59/M OD 2 N 506 546 41 8 597 665 68 11
7 78/M OD 2 N 270 292 21 8 340 360 20 6
8 51/M OD 2 N 349 382 33 9 411 476 65 16
9 70/M OD 2 N 308 307 −2 −1 251 254 3 1
10 68/M OS 2 Y 353 374 21 6 332 348 16 5
11 39/F OD 1 Y 261 285 24 9 282 319 37 13
12 53/M OD 2 Y 230 236 6 3 204 214 10 5
Mean 56.6 316 336 21 6 336 376 40 11
SD 10.7 72 81 15 4 103 122 34 10
Table 2.
 
Visual Acuity, MABP, and Plasma Glucose in Patients with DME
Table 2.
 
Visual Acuity, MABP, and Plasma Glucose in Patients with DME
Pt. No. Visual Acuity (ETDRS Letters) MABP (mm Hg) Plasma Glucose (mM)
Evening Morning Absolute Difference Relative Difference (%) Evening Morning Absolute Difference Relative Difference (%) Evening Morning Absolute Difference Relative Difference (%)
1 35 35 0 0 111 130 19 17 5.1 6.3 1.2 23.5
2 43 27 −16 −37 98 101 3 3 11.0 9.3 −1.7 −15.5
3 46 44 −2 −4 108 83 −25 −23 N/A N/A 0.0
4 61 59 −2 −3 105 97 −8 −8 7.9 5.2 −2.7 −34.2
5 53 47 −6 −11 106 109 3 3 N/A N/A 0.0
6 4 19 15 375 89 105 16 18 7.1 8.1 1.0 14.1
7 35 32 −3 −9 90 100 10 11 10.4 10.6 0.2 1.9
8 35 26 −9 −26 104 125 21 21 4.7 5.1 0.4 8.5
9 43 35 −8 −19 118 123 5 4 6.7 5.4 −1.3 −19.4
10 50 45 −5 −10 108 110 2 2 N/A N/A 0.0
11 47 29 −18 −38 97 97 0 0 4.4 10.1 5.7 129.5
12 41 29 −12 −29 103 82 −21 −20 14.3 7.8 −6.5 −45.5
Mean 41 36 −6 16 103 105 2 2 8 8 0 7.0
SD 14 11 9 114 8 15 14 14 3 2 3 51.3
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×